[{"NetIncomeLoss_1_Q3_USD":-13684000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":33273597.0,"CommitmentsAndContingencies_0_Q3_USD":null,"LiabilitiesNoncurrent_0_Q3_USD":665000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-3000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":18800000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-960000.0,"Depreciation_3_Q3_USD":651000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1138657.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":168255.0,"AssetsCurrent_0_Q3_USD":195456000.0,"OperatingLeaseExpense_3_Q3_USD":900000.0,"OperatingLeaseExpense_1_Q3_USD":300000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4894249.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":682000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":81000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":33361188.0,"Assets_0_Q3_USD":199935000.0,"ShareBasedCompensation_3_Q3_USD":4188000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":32954727.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1381000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5602000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":23293000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":8109000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1473000.0,"PaymentsOfFinancingCosts_3_Q3_USD":360000.0,"ProceedsFromStockPlans_3_Q3_USD":352000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":42000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":16000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":3000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":833000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1240000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":2409000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":191461000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":296000.0,"Liabilities_0_Q3_USD":7400000.0,"DefinedContributionPlanCostRecognized_3_Q3_USD":240000.0,"DefinedContributionPlanCostRecognized_1_Q3_USD":80000.0,"OperatingLeaseLiability_0_Q3_USD":1415000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":15165000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":290000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":58000.0,"CommonStockSharesOutstanding_0_Q3_shares":33361188.0,"RestrictedCashNoncurrent_0_Q3_USD":205000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1785000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-31290000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1102000.0,"LiabilitiesCurrent_0_Q3_USD":6735000.0,"AccountsPayableCurrent_0_Q3_USD":1095000.0,"NonoperatingIncomeExpense_3_Q3_USD":776000.0,"NonoperatingIncomeExpense_1_Q3_USD":27000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3615000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1248000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":67000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0702,"AdditionalPaidInCapital_0_Q3_USD":288249000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":191666000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":352000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":76000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2893000.0,"NetIncomeLoss_3_Q3_USD":-37682000.0,"DeferredFinanceCostsCurrentNet_0_Q3_USD":378000.0,"InterestReceivableCurrent_0_Q3_USD":2000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-31010000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":205000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":55000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"OperatingIncomeLoss_3_Q3_USD":-38458000.0,"OperatingIncomeLoss_1_Q3_USD":-13711000.0,"InvestmentIncomeInterest_3_Q3_USD":734000.0,"InvestmentIncomeInterest_1_Q3_USD":11000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":199935000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4188000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1785000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1119000.0,"OperatingExpenses_3_Q3_USD":38458000.0,"OperatingExpenses_1_Q3_USD":13711000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":2153000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.14,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.41,"ProfitLoss_3_Q3_USD":-37682000.0,"OtherLiabilitiesCurrent_0_Q3_USD":255000.0,"StockholdersEquity_0_Q3_USD":192535000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":960000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-95717000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":559000.0,"Ticker":"STOK","CIK":"1623526","name":"STOKE THERAPEUTICS, INC.","OfficialName":"Stoke Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"702726891.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]